×

Treating Tumors with TTFields and an Aurora Kinase Inhibitor

  • US 20190307781A1
  • Filed: 04/08/2019
  • Published: 10/10/2019
  • Est. Priority Date: 04/09/2018
  • Status: Active Grant
First Claim
Patent Images

1. A method of reducing viability of cancer cells, the method comprising:

  • administering an Aurora kinase inhibitor to the cancer cells; and

    applying an alternating electric field to the cancer cells, the alternating electric field having a frequency between 100 and 300 kHz.

View all claims
  • 6 Assignments
Timeline View
Assignment View
    ×
    ×